137 related articles for article (PubMed ID: 38189554)
1. PANoptosis-related signature in melanoma: Transcriptomic mapping and clinical prognostication.
Xie J; Zhang P; Xu X; Zhou X; Zhao S; Zhang M; Qi M
Environ Toxicol; 2024 May; 39(5):2545-2559. PubMed ID: 38189554
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic analysis reveals molecular characterization and immune landscape of PANoptosis-related genes in atherosclerosis.
Zheng Z; Li K; Yang Z; Wang X; Shen C; Zhang Y; Lu H; Yin Z; Sha M; Ye J; Zhu L
Inflamm Res; 2024 Jun; 73(6):961-978. PubMed ID: 38587531
[TBL] [Abstract][Full Text] [Related]
3. PANoptosis-related prognostic signature predicts overall survival of cutaneous melanoma and provides insights into immune infiltration landscape.
Wang W; Zhou Q; Lan L; Xu X
Sci Rep; 2023 May; 13(1):8449. PubMed ID: 37231081
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the metabolic landscape of cutaneous melanoma: Insights from single-cell sequencing analysis and machine learning for prognostic assessment of lactate metabolism.
Xie J; Zhang P; Ma C; Tang Q; Zhou X; Xu X; Zhang M; Zhao S; Zhou L; Qi M
Exp Dermatol; 2024 Jun; 33(6):e15119. PubMed ID: 38881438
[TBL] [Abstract][Full Text] [Related]
5. Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy.
Yi X; Li J; Zheng X; Xu H; Liao D; Zhang T; Wei Q; Li H; Peng J; Ai J
Mol Ther Nucleic Acids; 2023 Sep; 33():376-390. PubMed ID: 37547288
[TBL] [Abstract][Full Text] [Related]
6. Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.
He P; Ma Y; Wu Y; Zhou Q; Du H
Front Endocrinol (Lausanne); 2023; 14():1164930. PubMed ID: 37455906
[TBL] [Abstract][Full Text] [Related]
7. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response.
Wei Y; Lan C; Yang C; Liao X; Zhou X; Huang X; Xie H; Zhu G; Peng T
Sci Rep; 2023 Sep; 13(1):14519. PubMed ID: 37666920
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer.
Zhuang L; Sun Q; Huang S; Hu L; Chen Q
Sci Rep; 2023 Mar; 13(1):3877. PubMed ID: 36890219
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis identifies genetic and molecular factors associated with prognostic clusters of PANoptosis in glioma, kidney and melanoma cancer.
Mall R; Kanneganti TD
Sci Rep; 2023 Nov; 13(1):20962. PubMed ID: 38017056
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing.
Liu W; Qu C; Wang X
Oncol Res; 2023; 31(4):543-567. PubMed ID: 37415739
[TBL] [Abstract][Full Text] [Related]
11. Cell death shapes cancer immunity: spotlighting PANoptosis.
Gao L; Shay C; Teng Y
J Exp Clin Cancer Res; 2024 Jun; 43(1):168. PubMed ID: 38877579
[TBL] [Abstract][Full Text] [Related]
12. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer.
Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z
Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337
[TBL] [Abstract][Full Text] [Related]
13. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer.
Wang X; Sun R; Chan S; Meng L; Xu Y; Zuo X; Wang Z; Hu X; Han Q; Dai L; Bai T; Yu Z; Wang M; Yang W; Zhang H; Chen W
Front Genet; 2022; 13():955355. PubMed ID: 36186438
[TBL] [Abstract][Full Text] [Related]
14. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
[TBL] [Abstract][Full Text] [Related]
15. It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects.
Gullett JM; Tweedell RE; Kanneganti TD
Cells; 2022 Apr; 11(9):. PubMed ID: 35563804
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.
Zhong L; Qian W; Gong W; Zhu L; Wang X
Cell Mol Biol (Noisy-le-grand); 2023 Aug; 69(8):1-8. PubMed ID: 37715443
[TBL] [Abstract][Full Text] [Related]
17. PANoptosis: Mechanisms, biology, and role in disease.
Sun X; Yang Y; Meng X; Li J; Liu X; Liu H
Immunol Rev; 2024 Jan; 321(1):246-262. PubMed ID: 37823450
[TBL] [Abstract][Full Text] [Related]
18. PANoptosis: A New Insight Into Oral Infectious Diseases.
Jiang W; Deng Z; Dai X; Zhao W
Front Immunol; 2021; 12():789610. PubMed ID: 34970269
[TBL] [Abstract][Full Text] [Related]
19. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer.
Pan H; Pan J; Li P; Gao J
Clin Immunol; 2022 May; 238():109019. PubMed ID: 35470064
[TBL] [Abstract][Full Text] [Related]
20. Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer.
Yu T; Cheng W; Zhang J; Wang T; Liu Y; Duan Y; Hu A; Feng J; Li M; Li Y; Zhang H; Rong Z; Shang Y; Shakila SS; Ma F; Guo B
J Cancer; 2024; 15(2):428-443. PubMed ID: 38169571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
